News
News from us and our partners
News
Crossover
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Tags
Topics
0 results
- News
Noema Pharma announces first patients dosed in Phase 2b study with Gemlapodect (NOE-105), a first-in-class investigational therapy for Tourette Syndrome
- News
AAVantgarde Founder and CSO is elected as President of the European Society of Gene and Cell Therapy (ESGCT)
- News
deepc and The AI Centre for Value-Based Healthcare enter partnership to accelerate and transform NHS adoption of radiology AI
- News
Bioptimus and Proscia collaborate to accelerate AI innovation in scientific research and drug development for improved patient care
- News
Enhanced data security and quality via ISO 27001:2022 and SOC 2 certifications enables Moon Surgical to deliver actionable insights to healthcare providers
- News
Gradient Denervation Technologies appoints Stanton Rowe to Board of Directors and receives FDA approval to expand early feasibility study
- News
AAVantgarde appoints Ms. Lauren Kaskiel as Chief Business Officer
- News
Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints
- News
Biotalys appoints Kamal El Mernissi as Chief Business Development Officer
- News
Biotalys announces closing of private placement
- News
Sofinnova welcomes Agnès Pauquet as Head of Human Resources
- News
Bio-engineering scale-up Qorium showcases cultivated leather breakthrough, signalling a key step towards commercialisation
- News
Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study
- News
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
- News
Pi-Cardia receives FDA market clearance for ShortCut™